Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 4, 2025 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Jun 4, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jun 4, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 26, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 26, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Dec 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 26, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Dec 26, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 29, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
042